| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/19/2012 | US20120014870 Diagnosis and Treatment of Cancer Using Anti-LGR7 Antibody |
| 01/19/2012 | CA2841866A1 Carbohydrate hapten-based anti-cancer vaccines and antibody drugs |
| 01/19/2012 | CA2805875A1 Antibody libraries |
| 01/19/2012 | CA2805572A1 Modified single domain antigen binding molecules and uses thereof |
| 01/19/2012 | CA2805479A1 Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and glutamic acid decarboxylase (gad) autoantigenic peptides |
| 01/19/2012 | CA2805478A1 Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides |
| 01/19/2012 | CA2805414A1 Anti-addl monoclonal antibody and uses thereof |
| 01/19/2012 | CA2805388A1 Stabilized formulations containing anti-ngf antibodies |
| 01/19/2012 | CA2805306A1 Diagnostic method for colitis |
| 01/19/2012 | CA2805200A1 Use of antibodies against icam-1 in the treatment of patients with relapsed cancer |
| 01/19/2012 | CA2805112A1 Humanized antibodies targeting the ec1 domain of cadherin-11 and related compositions and methods |
| 01/19/2012 | CA2805094A1 Combination pharmaceutical composition and methods of treating genitourinary system disorders |
| 01/19/2012 | CA2805091A1 Pharmaceutical compositions and methods of treatment |
| 01/19/2012 | CA2804969A1 A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
| 01/19/2012 | CA2804966A1 A method of increasing the effect of an activated-potentiated form of an antibody |
| 01/19/2012 | CA2804964A1 Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract |
| 01/19/2012 | CA2804185A1 Multifunctional antibody conjugates |
| 01/19/2012 | CA2801996A1 Novel antibody for the diagnosis and/or prognosis of cancer |
| 01/19/2012 | CA2799036A1 Superior efficacy of cd37 antibodies in cll blood samples |
| 01/18/2012 | EP2407787A2 Method for detection of L523S expression in biological samples |
| 01/18/2012 | EP2407784A1 Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases |
| 01/18/2012 | EP2407537A1 Humanized pcrv antibody having anti-pseudomonal activity |
| 01/18/2012 | EP2407487A1 Multispecific modular antibody |
| 01/18/2012 | EP2407486A1 Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders |
| 01/18/2012 | EP2407485A1 High affinity anti-human IgE antibodies |
| 01/18/2012 | EP2406635A1 A method for predicting the responsiveness to an anti-tnf alpha antibody treatment |
| 01/18/2012 | EP2406395A1 Diagnosis and treatment of cell proliferation and differentiation disorders based on the fmn2 gene |
| 01/18/2012 | EP2406290A2 Antigen presenting cell targeted cancer vaccines |
| 01/18/2012 | EP2406289A2 Antigen presenting cell targeted anti-viral vaccines |
| 01/18/2012 | EP2406288A2 Antigen presenting cell targeted vaccines |
| 01/18/2012 | EP2406287A1 Antibodies binding to pivka-ii amino acids 13-27 |
| 01/18/2012 | EP2406286A2 Anti-cd40 antibodies and uses thereof |
| 01/18/2012 | EP2406285A1 Generation, expression and characterization of the humanized k33n monoclonal antibody |
| 01/18/2012 | EP2406284A2 Anti-bcma antibodies |
| 01/18/2012 | EP2406283A1 Antibody molecules having binding specificity for human il-13 |
| 01/18/2012 | EP2406280A1 Biological materials and uses thereof |
| 01/18/2012 | EP2405940A1 Antibodies to clostridium difficile toxins |
| 01/18/2012 | EP2405938A2 Nontypable haemophilus influenzae antigens |
| 01/18/2012 | EP2262839B1 Use of an anti-cd151 antibody for early treatment of cancer |
| 01/18/2012 | EP1928915B1 An ultra-high yield intravenous immune globulin preparation |
| 01/18/2012 | EP1848744B1 Human anti-interferon gamma antibodies and methods of use thereof |
| 01/18/2012 | EP1810690B1 Anti-IL-5 receptor antibody for use in treating endometriosis. |
| 01/18/2012 | EP1808446B1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 01/18/2012 | EP1743940B1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide |
| 01/18/2012 | EP1644044B1 Modified antibody fragments |
| 01/18/2012 | EP1553975B1 Optimized fc variants and methods for their generation |
| 01/18/2012 | EP1454138B1 Immunocytokines with modulated selectivity |
| 01/18/2012 | EP1257822B1 Her-2 binding antagonists |
| 01/18/2012 | EP1053256B9 Antibodies to death receptor 4 (dr4) and uses thereof |
| 01/18/2012 | CN1951962B Polypeptide for preparing antineoplastic antibody and its uses |
| 01/18/2012 | CN102326083A Method for inhibiting neurodegeneration |
| 01/18/2012 | CN102326075A Cellulose gel for purification of immunoglobulin |
| 01/18/2012 | CN102325903A Method for obtaining immunoglobulin encoding nucleic acid |
| 01/18/2012 | CN102325885A Methods and compositions for diagnosis and treatment of cancer |
| 01/18/2012 | CN102325884A Hypo-immunogenic streptavidin and use thereof |
| 01/18/2012 | CN102325796A Anti-human [alpha]9 integrin antibody and use thereof |
| 01/18/2012 | CN102325795A Antibodies against tissue factor pathway inhibitor |
| 01/18/2012 | CN102325794A EGFR-homing double-stranded rna vector for systemic cancer treatment |
| 01/18/2012 | CN102325793A Myostatin binding proteins |
| 01/18/2012 | CN102325792A Means and methods for manufacturing highly pure neurotoxin |
| 01/18/2012 | CN102325549A Treatment of cancer with umanized anti-egfr igg1 antibody and irinotecan |
| 01/18/2012 | CN102323415A Immunochromatography test paper for detecting Ciprofloxacin and preparation method thereof |
| 01/18/2012 | CN102323414A Phenobarbital homogeneous-phase enzyme immunoassay reagent kit and preparation method thereof |
| 01/18/2012 | CN102321923A Preparation method for monoclonal antibody library of tumor mucoprotein glycopeptide epitope |
| 01/18/2012 | CN102321653A Applications of man-mouse chimeric CD4 (cluster of differentiation 4) plasmid and multiclonal antibody in inhibiting HIV (human immunodeficiency virus) infection |
| 01/18/2012 | CN102321636A Protein for gene recombinant prokaryotic expression of duck plague virus gG as well as preparation method and application thereof |
| 01/18/2012 | CN102321177A Anti-melamine single-chain antibody and application thereof |
| 01/18/2012 | CN102321176A Method for preparing CysC-paired monoclonal antibody |
| 01/18/2012 | CN102321175A Nano-antibody or polypeptide aiming at breast cancer Her2/new |
| 01/18/2012 | CN102321174A IL-31 monoclonal antibodies and methods of use |
| 01/18/2012 | CN102321173A Humanized macrophage inhibitory factor 1 monoclonal antibody and application thereof |
| 01/18/2012 | CN102321172A Method for separation and preparation of livestock serum immunoglobulin powder with ferric salt |
| 01/18/2012 | CN102321167A Antigen epitope peptide of alpha fetoprotein, nucleic acid, preparation method of nucleic acid, recombinant vector, host cell, hybridoma cell, monoclonal antibody and kit |
| 01/18/2012 | CN102319431A Monoclonal antibody for detecting and treating senile dementia |
| 01/18/2012 | CN102319429A Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 01/18/2012 | CN101014364B Anti-ngf antibodies and methods using same |
| 01/17/2012 | US8097705 Methods and compositions for treating allergic diseases |
| 01/17/2012 | US8097704 Antibody specifically binding to DR5 and composition for preventing or treating cancers comprising the same |
| 01/17/2012 | US8097703 CD19 antibodies and their uses |
| 01/17/2012 | US8097701 Aldehyde tags, uses thereof in site-specific protein modification |
| 01/17/2012 | US8097700 TAT294 polypeptides |
| 01/17/2012 | US8097598 Porcine CTLA-4 for xenograft-specific immunosuppression |
| 01/17/2012 | US8097436 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 01/17/2012 | US8097430 Antigen targeting |
| 01/17/2012 | US8097255 Mammalian receptor protein DCRS5; methods of treatment |
| 01/17/2012 | US8097254 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 01/17/2012 | US8097253 Methods for inhibiting angiogenesis |
| 01/17/2012 | US8097252 Methods and compositions for administering therapeutic and diagnostic agents |
| 01/17/2012 | US8097251 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 01/17/2012 | US8097250 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 01/17/2012 | CA2604357C P-cadherin antibodies |
| 01/17/2012 | CA2457362C Human monoclonal rabies virus neutralizing antibodies, and methods for making and using the same |
| 01/17/2012 | CA2451353C Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 01/17/2012 | CA2446390C Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 01/17/2012 | CA2441958C Il-28 polypeptides and polynucleotids |
| 01/17/2012 | CA2413195C Ligand to gpr8 and dna thereof |
| 01/17/2012 | CA2370290C Method to distinguish prostate cancer from benign prostatic hyperplasia |
| 01/17/2012 | CA2148712C Peripheralization of hematopoietic stem cells |
| 01/12/2012 | WO2012006635A1 Processable single chain molecules and polypeptides made using same |
| 01/12/2012 | WO2012006596A2 Anti-human respiratory syncytial virus (rsv) antibodies and methods of use |